BioSpace News Archive

With the Thanksgiving holiday fast-approaching in the United States, some investors are giving their thanks to five different pharma companies that became available on the stock exchange this month with an initial public offering.

Motif Bio plc announces that formal notice was given by the Company to Nasdaq on November 25, 2019 of the intention to voluntarily delist the Company’s American Depository Shares and listed warrants from the Nasdaq Capital Market.

The company’s shares exploded 300% in after-hours trading yesterday at the news, giving the company a market value of $469.6 million.

Alimera Sciences, Inc. announces that Rick Eiswirth, President and Chief Executive Officer of Alimera, will participate in the 31st Annual Piper Jaffray Healthcare Conference in New York City on December 3, 2019.

BeiGene, Ltd. announced that the company will present at the 31st Annual Piper Jaffray Healthcare Conference in New York, NY.

In light of the Thanksgiving season, here are six things about biopharma that we are thankful for.

The press release will be available on the Company’s website (www.kewaunee.com) after it has been issued.

As we begin the final month of 2019, the U.S. Food and Drug Administration has several PDUFA dates to approve drug applications.

LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it has appointed senior finance executive Jeffrey A. Davis, current CFO of Qurate Retail Group and former CFO of J. C. Penney Company Inc., to its board of directors effective Dec. 1

Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced that the company’s management is scheduled to participate in the upcoming Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel in New York City.